Introduction

Imagine being a teenager who notices that your arms will not fully straighten or that your ankles feel unusually tight. At first, it may seem like harmless stiffness. However, over time, muscle weakness develops, and for some, heart rhythm problems emerge. This is the reality for many people living with Emery-Dreifuss Muscular Dystrophy (EDMD), a rare, inherited condition that affects both the muscles and the heart.

EDMD is not as widely known as other muscular dystrophies, yet it presents unique challenges. Its early signs can be subtle, but the risk of serious cardiac complications makes awareness and timely diagnosis essential. 

What is Emery-Dreifuss Muscular Dystrophy?

EDMD is a rare type of muscular dystrophy. This is a condition that causes muscles to weaken over time. A key feature that sets EDMD apart is that joint stiffness (contractures) often shows up early, sometimes before noticeable muscle weakness. Symptoms typically begin in childhood or adolescence, though the age of onset can vary between subtypes and even within the same family.¹

EDMD matters not only because of its effect on mobility, but also because it can affect the heart’s electrical system, causing rhythm problems (arrhythmias) or conduction block (signals travel too slowly or get interrupted). These can be dangerous, if missed. Early diagnosis and regular follow-up can enable heart devices such as pacemakers or defibrillators to be offered at the right time.¹

Genetics and Subtypes of EDMD

EDMD develops due to mutations (pathogenic variants) in genes that help maintain the structure of muscle and heart cells. These genes produce proteins that act like scaffolding, keeping the cell’s nucleus (control centre) stable. When the scaffolding is weakened, muscles gradually deteriorate, and the heart’s electrical system can become disrupted.^1,2

EDMD can be passed down in different ways. While symptoms overlap across subtypes, understanding the genetic cause helps anticipate problems, in particular cardiac risks, and helps guide family planning and testing.

Well-known genes include:^1,2

• EMD: makes emerin, which is a protein that helps stabilise the nuclear envelope in muscle cells
• LMNA: makes lamin A/C, which are structural proteins that support the nuclear membrane
• FHL1, SYNE1, SYNE2 and others: less common causes that are still being researched

X-linked EDMD

Often called EDMD1, it is caused by variants in the EMD gene or the FHL1 gene.^1,2,3

• Typically affects males more severely because they have only one X chromosome. Females with one altered copy are known as ‘carriers’ and may have no or mild symptoms (sometimes limited to heart involvement)
• Typically develops during childhood or early teen years
• Early contractures, slowly progressing arm/leg weakness, and later cardiac conduction disease

Autosomal dominant EDMD 

Often called EDMD2 and is commonly caused by variants in the LMNA gene.^1,2,3

• One altered copy is enough to cause the condition, therefore, any sex can be affected
• Typically develops from adolescence to adulthood
• Muscle weakness may extend from the upper arms/lower legs to the shoulders/hips, and can result in severe loss of walking ability. Cardiac disease may develop earlier and more severely, with a higher risk of dangerous arrhythmias (irregular heartbeat) and sudden cardiac death
• It is also possible for EDMD to arise from a new (de novo) variant with no previous family history. This is more commonly seen in an autosomal dominant disease

Autosomal recessive EDMD

Often called EDMD3.^1,2,3

• Requires two altered copies of the gene, one from each parent, who is usually a healthy carrier
• This subtype can develop at variable times
• This form is rare and can resemble other subtypes

Other genetic variants 

These are less common but show that EDMD can be caused by multiple genes, e.g SYNE1, SYNE2. Ongoing research continues to investigate how these genes influence symptoms and risks.^1,2,3

Clinical Presentation: Signs and Symptoms

EDMD is often recognised by three characteristic signs.

Early Joint Contractures

A contracture is the tightening and shortening of muscles and surrounding tissues that reduces the range of movement in a joint. In EDMD, contractures often appear early, sometimes before muscle weakness, and commonly affect the elbows, ankles (Achilles tendons), and neck. This could mean that day-to-day patients experience: 

• Difficulty fully straightening their elbows or turning their head
• Increasing stiffness in the neck and spine (spinal rigidity) over time
• ‘Toe-walking’ from tight Achilles tendons

Contractures are not necessarily painful but can make walking, sitting, and exercise more difficult. They tend to get worse if not properly managed.^1,3,4

Progressive Muscle Weakness and Wasting

Weakness often begins in the upper arms and lower legs (sometimes called a “humeroperoneal” pattern). Over time, the shoulder and hip/thigh muscles may become involved, making activities such as lifting arms overhead, climbing stairs, or getting up from a chair harder. 

Progression is usually slow in the first decades, though the pace can vary; some people remain mobile for many years. Others may eventually require a wheelchair, this is more often described in autosomal dominant (LMNA-related) disease than in X-linked EDMD.^1,3,4

Cardiac Involvement

Heart problems are the most serious aspect of EDMD and can occur even when muscle symptoms are relatively mild. They include:

• Conduction defects: slowed or blocked electrical signals; may cause light-headedness, fainting (syncope), or very slow heart rates
• Arrhythmias: irregular heart rhythms (e.g., atrial fibrillation, flutter, supraventricular or ventricular arrhythmias) that may cause palpitations, breathlessness, or fatigue
• Cardiomyopathy: structural changes (often dilated cardiomyopathy) that reduce the heart’s pumping ability and can lead to heart failure

In some people, a sudden cardiac event can be the first noticeable sign of EDMD, which is why routine screening is important for anyone with a suggestive history or diagnosis.^1,3,4,5

Other Symptoms

• Respiratory involvement as weakness progresses: disturbed sleep, morning headaches, daytime sleepiness, or recurrent chest infections
• Spinal rigidity and occasional scoliosis (curvature of the spine)

It is important to note that there is a lot of variability in onset and severity, even among relatives with the same subtype.^1,3,4

Diagnosis

Diagnosis combines careful clinical assessment with heart examinations and genetic confirmation.^1,4

• History and physical examination: doctors will look for the triad (early contractures, pattern of weakness, cardiac symptoms) and any family history that suggests inheritance
• Blood tests: creatine kinase (CK) levels can be normal or mildly raised
• Heart tests: ECG, echocardiogram, and Holter monitoring (24-hour ECG) to detect conduction defects and arrhythmias. This is crucial even if the patient feels well
• Genetic testing: to confirm the subtype, enable family screening, and guide monitoring
• Electrodiagnostic studies and muscle biopsy may be used if the diagnosis remains unclear; biopsy is needed less often now that genetic testing is widely available

As EDMD is inherited, it is recommended to screen relatives, including female carriers of X-linked forms, particularly to evaluate their cardiovascular (heart) health. 

Complications and Prognosis

Potential complications can include:^1,4

• Cardiac events: fainting, stroke due to irregular rhythms, heart failure, or sudden cardiac death if arrhythmias go untreated
• Mobility limitations: from contractures and muscle weakness, affecting daily activities and independence
• Respiratory issues: reduced breathing strength, disturbed sleep, and a higher risk of chest infections

Outlook

With timely cardiac care (including pacemakers or implantable defibrillators when indicated), many people with EDMD enjoy long, productive lives. Prognosis (the likely outcome) varies by subtype; those with LMNA-related (autosomal dominant) EDMD often require greater heart surveillance due to higher arrhythmia risk.^1,4,5

Summary

Emery-Dreifuss muscular dystrophy (EDMD) is a rare, inherited condition that affects both the muscles and the heart. It is most often recognised by a triad of early joint contractures, slowly progressive muscle weakness, and potentially life-threatening cardiac complications. Symptoms usually begin in childhood or adolescence, with patients often noticing stiff elbows, tight ankles, or difficulty turning the neck before muscle weakness develops. Over time, weakness can spread from the arms and legs to the shoulders and hips, affecting mobility. The most serious risks, however, are heart conduction defects and arrhythmias, which can sometimes cause sudden cardiac events if left undetected. 

EDMD has several subtypes: X-linked, autosomal dominant, and autosomal recessive, each with slightly different inheritance patterns and cardiac risks. Diagnosis relies on clinical assessment, heart monitoring, and genetic testing, which also supports family counselling. While there is currently no cure, management focuses on cardiac care, physiotherapy, and supportive treatments to maintain independence and quality of life. With early diagnosis and regular heart monitoring, the slow progressive nature of EDMD means that many patients can still live long and fulfilling lives.